Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

September 3, 2019

The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease

August 14, 2019

Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in...

C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting

The collaborative project between the organizations will kick off at a launch meeting in September and will aim to r

August 1, 2019

July 4, 2019

TUCSON, Ariz., July 2, 2019 — The Critical Path Institute (C-Path) is pleased to announce that after an extensive

June 25, 2019

The Critical Path for Parkinson’s consortium (CPP) is pleased to announce the following recipients as the first to receive C

The document serves as a guide to the analysis of biomarkers in drug development TUCSON, Ariz., June 11, 2019 — The Critical Pat